Table 1 Clinical characteristics of Ovarian Cancer cases by tumor subtype (2000–2015)
From: Prevalence of breast and ovarian cancer subtypes in Hispanic populations from Puerto Rico
|  | Total n = 170 | Clear/Squamous n = 4 | Endometrioid n = 17 | Mucinous n = 13 | Serous n = 110 | Other n = 11 | Not spec n = 15 |
|---|---|---|---|---|---|---|---|
Overall % by subtypes | 100% | 2.35% | 10% | 7.65% | 64.71% | 6.47% | 8.82% |
Age Mean (SD) years | 60.36 (12.64) | 55.75 (20.41) | 54.47 (11.47) | 53.46 (11.34) | 61.43 (12.17) | 60.18 (15.05) | 66.6 (11.04) |
Location | |||||||
 South | 141 (82.94%) | 4 (100%) | 14 (82.35%) | 11 (84.62%) | 90 (81.82%) | 9 (81.82%) | 13 (86.67%) |
 West | 28 (16.47%) | 0 | 3 (17.65%) | 2 (15.38%) | 19 (17.27%) | 2 (18.18%) | 2 (13.33%) |
 North | 1 (0.59%) | 0 | 0 | 0 | 1 (0.91%) | 0 | 0 |
 Missing | – | – | – | – | – | – | – |
Grade | |||||||
 Other | 2 (1.18%) | 0 | 0 | 0 | 2 (1.82%) | 0 | 0 |
 G1 | 30 (17.65%) | 1 (25%) | 8 (47.06%) | 7 (53.85%) | 13 (11.82%)%) | 0 | 1 (6.67%) |
 G2 | 33 (19.41%) | 1 (25%) | 7 (41.18%) | 0 | 24 (21.82%) | 1 (9.09%) | 0 |
 G3 | 82 (48.24%) | 2 (50%) | 1 (5.88%) | 1 (7.69%) | 66 (60%) | 6 (54.55%) | 6 (40%) |
 Missing | 23 | 0 | 1 | 5 | 5 | 4 | 8 |
Stage | |||||||
 Borderline | 1 (0.59%) | 0 | 0 | 0 | 1 (0.91%) | 0 | 0 |
 S1 | 61 (35.88%) | 2 (50%) | 13 (76.47%) | 6 (46.15%) | 31 (28.18%) | 7 (63.64%) | 2 (13.33%) |
 S2 | 25 (14.71) | 0 | 1 (5.88%) | 1 (7.69) | 20 (18.18%) | 0 | 3 (20%) |
 S3 | 59 (34.71) | 0 | 1 (5.88%) | 4 (30.77%) | 44 (40%) | 2 (18.18%) | 8 (53.33%) |
 S4 | 8 (4.71%) | 0 | 1 (5.88%) | 0 | 5 (4.55%) | 0 | 2 (13.33%) |
 Missing | 16 | 2 | 1 | 2 | 9 | 2 | 0 |
Cancer type | |||||||
 Invasive | 9 (5.3%) | 1 (25%) | 1 (5.88%) | 1 (7.69%) | 5 (4.55%) | 0 | 1 (6.67%) |
 Metastatic | 86.0 (50.6%) | 0 | 2 (11.76%) | 5 (38.46%) | 62 (56.36%) | 4 (36.36%) | 13 (86.67%) |
 Missing | 75 | 3 | 14 | 7 | 43 | 7 | 1 |